Recognition and progress of idiopathic intracranial hypertension

VernacularTitle:特发性颅内压增高的认识及进展
Author: Lan XIANG ¹ ; Zhihong ZHAO ; Bin XIANG
Author Information

1. 湖南师范大学附属第一医院（湖南省人民医院）神经内科，长沙　410005
Keywords: Idiopathic intracranial hypertension; Obesity; Papilledema; New targeted drugs
From: Journal of Chinese Physician 2023;25(1):157-160,F3
CountryChina
Language:Chinese
Abstract: Idiopathic intracranial hypertension (IIH) is a syndrome of unexplained increased intracranial pressure with normal cerebrospinal fluid and without organic brain lesions. The etiology and pathogenesis of IIH remain unclear, and IIH patients may develop irreversible visual impairment. At present, there are no guidelines and expert consensus on diagnosis and treatment of IIH in China. This review aims to introduce the pathogenesis, diagnosis and treatment of IIH, in order to help clinicians improve their understanding of the disease and to identify, diagnose and treat IIH as early as possible, and improve the prognosis of patients.